Aurobindo Pharma Ends At One-Month High On Best Revenue, Ebitda In Two Years
A man rides past an Aurobindo Pharma production facility in Jadcherla, India. (Photographer: Prashanth Vishwanathan/Bloomberg)

Aurobindo Pharma Ends At One-Month High On Best Revenue, Ebitda In Two Years

Shares of Aurobindo Pharma Ltd. rose to the highest in a month after the Hyderabad-based drugmaker reported its best quarterly revenue and operating profit in at least two years.The company’s reven...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.